FIELD: biotechnology.
SUBSTANCE: present invention refers to new immunogens based on overlapping peptides (OLP), and can be used in medicine for preventing or treating HIV infection. Immunogenic fused protein consisting of polypeptide segments connected by amino acid linkers is obtained. Present invention also relates to isolated nucleic acids, vectors and host cells expressing these immunogens, as well as vaccines containing said immunogens.
EFFECT: invention provides induction of HIV-specific T-cell immune responses in a host.
36 cl, 8 dwg, 5 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| VIRUS-LIKE PARTICLES WITH HIGH-DENSITY COATING FOR INDUCTION OF ANTIBODY EXPRESSION | 2017 |
|
RU2813282C2 |
| IMMUNOGENIC COMPOSITION AGAINST SUBTYPE H5 AVIAN FLU VIRUS | 2019 |
|
RU2809084C2 |
| ARTIFICIAL GENES CODING EV.CTL AND EV.Th PROTEINS-IMMUNOGENS, RECOMBINANT PLASMID DNA pEV.CTL AND EV.Th, PROVIDING EXPRESSION OF ARTIFICIAL GENES, AND ARTIFICIAL T-CELL POLYEPITOPE PROTEINS-IMMUNOGENS EV.CTL AND EV.Th CONTAINING EPITOPES OF EBOLA VIRUS ANTIGENS, USED TO CREATE AN EBOLA VIRUS VACCINE | 2018 |
|
RU2713723C1 |
| GENE THERAPY OF HYPOPHOSPHATEMIC DISEASES ASSOCIATED WITH FIBROBLAST GROWTH FACTOR 23 | 2020 |
|
RU2815545C2 |
| PNEUMOCOCCAL VACCINE COMBINING SELECTED ALPHA HELICAL DOMAINS AND PROLINE-RICH DOMAINS OF PNEUMOCOCCAL SURFACE PROTEIN A | 2017 |
|
RU2794625C2 |
| BISPECIFIC ANTIBODY | 2020 |
|
RU2814713C2 |
| MATERIALS AND METHODS USED FOR TREATMENT OF RESPIRATORY DISEASES IN DOGS | 2020 |
|
RU2811752C2 |
| VACCINE TO SWINE INFLUENZA A VIRUS | 2018 |
|
RU2787596C2 |
| SUBUNIT VACCINE FOR TREATING OR PREVENTING RESPIRATORY TRACT INFECTION | 2020 |
|
RU2811991C2 |
| IL2 AND MUTANT TNF IMMUNOCONJUGATES | 2017 |
|
RU2758139C2 |
